| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.7M | -5.8% |
| Cost of Revenue | $21.9M | +6.3% |
| Gross Profit | $20.8M | -16.0% |
| R&D Expense | $13.1M | +22.1% |
| SG&A Expense | $34.0M | +86.9% |
| Operating Income | -$80.1M | -60.7% |
| Interest Expense | $6.4M | +102.0% |
| Pre-tax Income | -$28.3M | +78.6% |
| Income Tax | $1.8M | -27.7% |
| Net Income | -$30.1M | +59.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.5M | -55.6% |
| Accounts Receivable | $4.2M | -38.2% |
| Current Assets | $23.7M | -48.0% |
| Total Assets | $138.8M | -22.8% |
| Current Liabilities | $67.3M | +201.3% |
| Long-term Debt | $120.3M | +64.8% |
| Total Liabilities | $162.9M | -7.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.5M | -12.4% |
| Capital Expenditures | $568K | -38.3% |
| Investing Cash Flow | -$568K | -100.5% |
| Financing Cash Flow | $46.5M | +196.1% |
| Free Cash Flow | -$59.1M | -11.6% |
| Stockholders' Equity |
| -$24.1M |
| -856.0% |